Skip to main content
Top
Published in: Diabetology International 3/2022

07-02-2022 | Gestational Diabetes | Original Article

Accuracy of capillary blood glucose for 50-g glucose challenge test for gestational diabetes screening

Authors: Dittakarn Boriboonhirunsarn, Amporn Robkhonburi, Maria Asad-dehghan

Published in: Diabetology International | Issue 3/2022

Login to get access

Abstract

Purpose

To assess the accuracy of capillary blood glucose (CBG) compared to conventional venous plasma glucose (VPG) testing for 50-g glucose challenge test (GCT) in gestational diabetes (GDM) screening.

Methods

A total of 300 women were enrolled and 50-g GCT for GDM screening was offered. At 1 h after glucose loading, CBG was evaluated by CONTOUR® PLUS glucose meter by well-trained nurses immediately after venipuncture for VPG. Results of CBG were compared with those from VPG to evaluate its accuracy. Women with venous plasma glucose > 140 mg/dL were offered 100-g OGTT for GDM diagnosis.

Results

The mean age was 30.2 years and the mean gestational age at testing was 21.8 weeks. GDM was diagnosed in 34 women (11.3%). The mean VPG was 142.1 ± 32.9 mg/dL and the mean CBG was 129.3 ± 33.5 mg/dL. Mean difference was −12.3 ± 12.5 mg/dL, corresponding to −8.8 ± 11.4%. CBG significantly correlated with VPG with correlation coefficient of 0.929, p < 0.001. In the detection of abnormal 50-g GCT results (VPG ≥ 140 mg/dL), at 126 mg/dL cutoff, CBG had sensitivity of 92.5%, specificity of 81.8%, and positive and negative predictive values of 82.8%and 92%. None of the GDM would have been missed if CBG was used.

Conclusion

CBG by a certified glucose meter could be considered as an alternative to conventional VPG testing for 50-g GCT for GDM screening using 126 mg/dL cutoff value.
Literature
1.
go back to reference American College of Obstetricians and Gynecologists. Committee on Practice Bulletins-Obstetrics. Practice Bulletin No 190: Gestational diabetes mellitus. Obstet Gynecol. 2018;131(2):49–64. American College of Obstetricians and Gynecologists. Committee on Practice Bulletins-Obstetrics. Practice Bulletin No 190: Gestational diabetes mellitus. Obstet Gynecol. 2018;131(2):49–64.
2.
go back to reference American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2021;44(Supplement 1):s15-33.CrossRef American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2021;44(Supplement 1):s15-33.CrossRef
3.
go back to reference Hod M, Kapur A, Sacks DA, Hadar E, Agarwal M, Di Renzo GC, et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet. 2015;131(Suppl 3):S173-211.CrossRef Hod M, Kapur A, Sacks DA, Hadar E, Agarwal M, Di Renzo GC, et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet. 2015;131(Suppl 3):S173-211.CrossRef
4.
go back to reference American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2020;43(Supplement 1):s77–88.CrossRef American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2020;43(Supplement 1):s77–88.CrossRef
5.
go back to reference Bhavadharini B, Mahalakshmi MM, Maheswari K, Kalaiyarasi G, Anjana RM, Deepa M, et al. Use of capillary blood glucose for screening for gestational diabetes mellitus in resource-constrained settings. Acta Diabetol. 2016;53(1):91–7.CrossRef Bhavadharini B, Mahalakshmi MM, Maheswari K, Kalaiyarasi G, Anjana RM, Deepa M, et al. Use of capillary blood glucose for screening for gestational diabetes mellitus in resource-constrained settings. Acta Diabetol. 2016;53(1):91–7.CrossRef
6.
go back to reference Buhling KJ, Henrich W, Kjos SL, Siebert G, Starr E, Dreweck C, et al. Comparison of point-of-care-testing glucose meters with standard laboratory measurement of the 50g-glucose-challenge test (GCT) during pregnancy. Clin Biochem. 2003;36(5):333–7.CrossRef Buhling KJ, Henrich W, Kjos SL, Siebert G, Starr E, Dreweck C, et al. Comparison of point-of-care-testing glucose meters with standard laboratory measurement of the 50g-glucose-challenge test (GCT) during pregnancy. Clin Biochem. 2003;36(5):333–7.CrossRef
7.
go back to reference Dhatt GS, Agarwal MM, Othman Y, Nair SC. Performance of the Roche Accu-Chek active glucose meter to screen for gestational diabetes mellitus using fasting capillary blood. Diabetes Technol Ther. 2011;13(12):1229–33.CrossRef Dhatt GS, Agarwal MM, Othman Y, Nair SC. Performance of the Roche Accu-Chek active glucose meter to screen for gestational diabetes mellitus using fasting capillary blood. Diabetes Technol Ther. 2011;13(12):1229–33.CrossRef
8.
go back to reference Balaji V, Madhuri BS, Paneerselvam A, Arthi T, Seshiah V. Comparison of venous plasma glucose and capillary whole blood glucose in the diagnosis of gestational diabetes mellitus: a community-based study. Diabetes Technol Ther. 2012;14(2):131–4.CrossRef Balaji V, Madhuri BS, Paneerselvam A, Arthi T, Seshiah V. Comparison of venous plasma glucose and capillary whole blood glucose in the diagnosis of gestational diabetes mellitus: a community-based study. Diabetes Technol Ther. 2012;14(2):131–4.CrossRef
9.
go back to reference Daly N, Carroll C, Flynn I, Harley R, Maguire PJ, Turner MJ. Evaluation of point-of-care maternal glucose measurements for the diagnosis of gestational diabetes mellitus. BJOG. 2017;124(11):1746–52.CrossRef Daly N, Carroll C, Flynn I, Harley R, Maguire PJ, Turner MJ. Evaluation of point-of-care maternal glucose measurements for the diagnosis of gestational diabetes mellitus. BJOG. 2017;124(11):1746–52.CrossRef
10.
go back to reference Adam S, Rheeder P. Evaluating the utility of a point-of-care glucometer for the diagnosis of gestational diabetes. Int J Gynaecol Obstet. 2018;141(1):91–6.CrossRef Adam S, Rheeder P. Evaluating the utility of a point-of-care glucometer for the diagnosis of gestational diabetes. Int J Gynaecol Obstet. 2018;141(1):91–6.CrossRef
11.
go back to reference Dickson LM, Buchmann EJ, Janse van Rensburg C, Norris SA. Accuracy of five plasma calibrated glucometers to screen for and diagnose gestational diabetes mellitus in a low resource clinic setting. J Clin Transl Endocrinol. 2019;16:100174. Dickson LM, Buchmann EJ, Janse van Rensburg C, Norris SA. Accuracy of five plasma calibrated glucometers to screen for and diagnose gestational diabetes mellitus in a low resource clinic setting. J Clin Transl Endocrinol. 2019;16:100174.
12.
go back to reference Srimaekarat T. Capillary blood glucose screening (Accu-Chek Advantage) for gestational diabetes. J Med Assoc Thai. 2009;92(10):1268–72.PubMed Srimaekarat T. Capillary blood glucose screening (Accu-Chek Advantage) for gestational diabetes. J Med Assoc Thai. 2009;92(10):1268–72.PubMed
13.
go back to reference Caswell M, Frank J, Viggiani MT, Pardo S, Dunne N, Warchal-Windham ME, et al. Accuracy and user performance evaluation of a blood glucose monitoring system. Diabetes Technol Ther. 2015;17(3):152–8.CrossRef Caswell M, Frank J, Viggiani MT, Pardo S, Dunne N, Warchal-Windham ME, et al. Accuracy and user performance evaluation of a blood glucose monitoring system. Diabetes Technol Ther. 2015;17(3):152–8.CrossRef
14.
go back to reference Ji LN, Guo LX, Liu LB. Accuracy and precision assessment of a new blood glucose monitoring system. Clin Chem Lab Med. 2016;54(1):181–8.CrossRef Ji LN, Guo LX, Liu LB. Accuracy and precision assessment of a new blood glucose monitoring system. Clin Chem Lab Med. 2016;54(1):181–8.CrossRef
15.
go back to reference Dunne N, Viggiani MT, Pardo S, Robinson C, Parkes JL. Accuracy evaluation of CONTOUR ® PLUS compared with four blood glucose monitoring systems. Diabetes Ther. 2015;6(3):377–88.CrossRef Dunne N, Viggiani MT, Pardo S, Robinson C, Parkes JL. Accuracy evaluation of CONTOUR ® PLUS compared with four blood glucose monitoring systems. Diabetes Ther. 2015;6(3):377–88.CrossRef
16.
go back to reference Pastakia SD, Njuguna B, Onyango BA, Washington S, Christoffersen-Deb A, Kosgei WK, et al. Prevalence of gestational diabetes mellitus based on various screening strategies in western Kenya: a prospective comparison of point of care diagnostic methods. BMC Pregnancy Childbirth. 2017;17(1):226.CrossRef Pastakia SD, Njuguna B, Onyango BA, Washington S, Christoffersen-Deb A, Kosgei WK, et al. Prevalence of gestational diabetes mellitus based on various screening strategies in western Kenya: a prospective comparison of point of care diagnostic methods. BMC Pregnancy Childbirth. 2017;17(1):226.CrossRef
Metadata
Title
Accuracy of capillary blood glucose for 50-g glucose challenge test for gestational diabetes screening
Authors
Dittakarn Boriboonhirunsarn
Amporn Robkhonburi
Maria Asad-dehghan
Publication date
07-02-2022
Publisher
Springer Nature Singapore
Published in
Diabetology International / Issue 3/2022
Print ISSN: 2190-1678
Electronic ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-022-00572-3

Other articles of this Issue 3/2022

Diabetology International 3/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine